Paraneoplastic Neuropathy

This is a nerve problem that happens because of cancer. The cancer doesn't directly attack the nerves, but it causes the body's immune system to mistakenly attack them. This leads to symptoms like numbness, tingling, or weakness, usually starting in the hands and feet.

Condition

What people with Paraneoplastic Neuropathy report

Every report comes from a Lived member, sent anonymously.

Have you tried Gabapentin for Paraneoplastic Neuropathy?

NameHow it went

About Paraneoplastic Neuropathy

What It Is

Paraneoplastic neuropathy is damage to the nerves outside the brain and spinal cord (the peripheral nerves) that happens because a person has cancer, but not because the tumor has spread to or pressed on those nerves. Instead, the body's response to the cancer, usually an immune reaction, ends up harming nerve tissue. It is rare, and it is different from the much more common nerve damage caused by chemotherapy. The most common early symptoms are numbness or loss of feeling and nerve pain, such as burning or electric sensations. Some people also develop weakness or unsteadiness when walking. In the classic form, called sensory neuronopathy, the illness damages the nerve cells that carry sensation and the sense of where the limbs are. It tends to come on over weeks rather than years, can affect one side more than the other and often starts in the hands or arms. Losing position sense can make walking, balance and fine hand movements very difficult even when muscle strength is normal. Other forms are milder or less specific: a gradual numbness and weakness in the feet and hands, or nerve problems that affect blood pressure, digestion, bladder control or sweating (autonomic neuropathy). The condition matters for two reasons. The nerve damage can be disabling, and it is sometimes the first sign of a cancer that has not yet been found.

Causes & Risk Factors

The underlying cause is a cancer. In most well-described cases, the tumor makes proteins that resemble proteins in nerve cells. The immune system attacks the tumor and mistakenly attacks nerves as well. Doctors can often detect this response as specific antibodies in the blood, such as anti-Hu, although the antibodies mainly serve as markers, and some people with the condition have none. Small cell lung cancer is the cancer most often involved. Other lung cancers, breast and ovarian cancer, thymoma (a tumor of the thymus gland in the chest) and some blood cancers such as lymphoma, myeloma and related conditions can also be responsible. A milder, slowly developing nerve problem can also appear in advanced cancer, often alongside weight loss and muscle wasting. It has no known antibody link and probably arises from the overall toll of the illness. Having cancer and neuropathy together does not automatically mean the neuropathy is paraneoplastic. Chemotherapy, diabetes, heavy alcohol use, vitamin B12 deficiency and simple aging are far more common explanations.

How It's Diagnosed

No single test confirms paraneoplastic neuropathy. Diagnosis rests on how the symptoms developed, what the nerve tests show, whether certain antibodies are present and whether a cancer is found. A neurologist examines sensation, strength, reflexes and balance. Nerve conduction studies and electromyography (EMG) measure electrical signals in nerves and muscles; they show which nerves are damaged and in what pattern. In sensory neuronopathy, for example, signals from sensory nerves are often absent while motor nerves look nearly normal. Blood tests check for paraneoplastic antibodies and for common causes of neuropathy such as diabetes, vitamin deficiencies, thyroid disease and abnormal blood proteins. A spinal fluid test is sometimes used. These nerve syndromes often appear before the cancer is diagnosed, so a suspected paraneoplastic neuropathy leads to a prompt search for cancer, with imaging scans and other tests chosen according to the type of neuropathy and antibody found. When a high-risk form of neuropathy and a high-risk antibody are both present but the first scans find nothing, guidelines recommend repeating the cancer search every 4 to 6 months for 2 years. For people already being treated for cancer, the main question is whether the neuropathy is paraneoplastic or a side effect of treatment. Chemotherapy-related nerve damage is far more common and usually follows the timing of treatment. Immunotherapy drugs called checkpoint inhibitors can also trigger immune attacks on nerves, typically within the first few treatment cycles.

Treatment Options

Treatment works on two fronts: the cancer and the nerves. Finding and treating the cancer, with surgery, chemotherapy or radiation, removes the source of the immune reaction and is the first priority. It may stop the nerve damage from getting worse. In the antibody-linked forms, though, nerves that are already damaged seldom recover much, even when cancer treatment succeeds. Treatments that calm the immune system may also be tried, including corticosteroids, intravenous immunoglobulin (IVIG, antibodies pooled from donated blood and given by infusion) and plasma exchange (a procedure that filters antibodies out of the blood). Evidence for these comes only from case reports and small series, not controlled trials. They seem to work best when started early, ideally within about the first two months of symptoms, before nerve cells are permanently lost. Forms involving antibodies to proteins on the nerve surface, and forms that resemble Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy (CIDP), respond to immune treatment more reliably. Neuropathy linked to myeloma and related blood disorders is managed by treating the blood disorder. Symptom relief is an essential part of care. Nerve pain is usually treated first with certain antidepressants (tricyclics or serotonin-norepinephrine reuptake inhibitors) or with gabapentin-type medicines, which reduce overactive pain signals; lidocaine patches or opioids are later options. Finding the right medicine and dose often takes several adjustments. Physical and occupational therapy, balance training, mobility aids and home safety changes help people stay active and reduce falls.

What to Expect

The course depends heavily on the type of neuropathy and the cancer behind it. The classic sensory form tends to worsen over weeks to a few months and then level off. Improvement afterward is usually limited, and many people are left with lasting numbness, pain and unsteadiness that can make walking, writing or dressing difficult and may require considerable help with daily life. Milder sensorimotor forms usually cause less disability. Overall outlook is also shaped by the cancer itself and how it responds to treatment. Daily life often involves adapting to reduced feeling: using sight to guide movements, taking care with stairs and uneven ground, checking hands and feet for injuries that cannot be felt, and pacing activities around fatigue and pain. Some people also notice dizziness on standing, constipation or bladder changes when autonomic nerves are involved. Follow-up usually includes regular neurology visits to track nerve function and adjust pain treatment, and ongoing cancer monitoring, including repeat scans when no tumor was found at first. Because the same immune response can sometimes affect the brain or spinal cord, new symptoms are reviewed carefully rather than assumed to be part of the neuropathy. Rehabilitation and practical support for caregivers become important when disability is significant.

When to Seek Help

See a doctor, ideally a neurologist, if numbness, burning pain or unsteadiness develops over weeks and keeps getting worse, especially if it affects the hands early, one side more than the other, or comes with unexplained weight loss. Early diagnosis matters, both for finding a cancer and because immune treatment works best before nerve damage settles in. Contact your cancer or neurology team promptly if you develop new numbness, weakness, double vision or facial weakness while receiving immunotherapy, or if existing symptoms suddenly worsen, or new problems appear such as memory changes, confusion, slurred speech or clumsiness. Weakness that spreads quickly over hours to days, or any trouble breathing or swallowing, needs emergency care.

Questions to Ask Your Doctor

  1. 1.What makes you think this neuropathy is related to cancer rather than chemotherapy, diabetes or another cause?
  2. 2.Which antibody and nerve test results do I have, and what do they suggest about where to look for cancer?
  3. 3.Is immune treatment worth trying in my case, how soon should it start, and how will we know whether it is helping?
  4. 4.If no cancer is found now, how often will I need repeat scans, and for how long?
  5. 5.What can physical or occupational therapy and pain treatment realistically do for my walking, balance and daily tasks?

Last reviewed • Oct 2026

Educational content, not medical advice.